These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 12815464

  • 1. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 2. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 4. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
    Spierings DC, de Vries EG, Stel AJ, te Rietstap N, Vellenga E, de Jong S.
    Oncogene; 2004 Jun 17; 23(28):4862-72. PubMed ID: 15122333
    [Abstract] [Full Text] [Related]

  • 5. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 6. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS.
    Cell Death Differ; 2002 Mar 15; 9(3):287-300. PubMed ID: 11859411
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P, Sun NK, Chao CC.
    Biochem J; 2003 Nov 15; 376(Pt 1):253-60. PubMed ID: 12911332
    [Abstract] [Full Text] [Related]

  • 8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Nov 15; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G.
    Arthritis Rheum; 2004 Feb 15; 50(2):498-506. PubMed ID: 14872492
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
    Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R.
    Cancer Res; 1997 Aug 15; 57(16):3331-4. PubMed ID: 9269989
    [Abstract] [Full Text] [Related]

  • 11. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 15; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 12. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 14. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 15. Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.
    Takada E, Shimo K, Hata K, Abiake M, Mukai Y, Moriyama M, Heasley L, Mizuguchi J.
    Exp Cell Res; 2005 Apr 01; 304(2):518-30. PubMed ID: 15748896
    [Abstract] [Full Text] [Related]

  • 16. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 01; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 01; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 18. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 19. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 20. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.
    Invest Ophthalmol Vis Sci; 2005 Jan 22; 46(1):358-66. PubMed ID: 15623796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.